Image For Activity Cover
Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

Listen to Dr. Matthew Powell and Dr. Wendel Naumann discuss the 2024 SGO Annual Meeting on Women’s Cancer late-breaking abstract Overall survival in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY 

Recorded on April 23, 2024
Duration approximately 15 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact

If you have questions or need assistance, contact

Faculty Information

Matthew A. Powell, MD
Professor, Div Gyn Oncology
Chair Uterine Corpus Committee
National Cancer Institute sponsored NRG Oncology
Washington University School of Medicine

R. Wendel Naumann, M.D.
Director of Gynecologic Oncology Research
Associate Medical Director of Clinical Trials
Levine Cancer Institute – Hall Gynecologic Oncology Center

Supported in part by
Availability: On-Demand
Cost: FREE
Contact for assistance.
Powered By